Fstl1 silencing significantly increased cells apoptosis (Fig. 2a) and decreased the proliferative ability of GBM cells after TMZ treatment (Fig. 2c and Supplementary Fig. 4B). This evidence concerns the gene FSTL1 and glioblastoma.